Search

everythinglearnresearchcommunity

for

Search:↓

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Male hormones control a specific gene in hamster skin, with different hormones having varying effects.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Ketoconazole's structure and dynamics are linked, aiding antifungal drug development.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

The plant combination effectively repairs skin and delays aging.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Dosing time affects finasteride's effectiveness and safety in rats.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.